Cargando…
A virus-like particle-based connective tissue growth factor vaccine suppresses carbon tetrachloride-induced hepatic fibrosis in mice
Connective tissue growth factor (CTGF) has been recognized as a central mediator and promising therapeutic target in hepatic fibrosis. In this study, we generated a novel virus-like particle (VLP) CTGF vaccine by inserting the 138–159 amino acid (aa) fragment of CTGF into the central c/e1 epitope of...
Autores principales: | Li, Shuang, Lv, Yi-Fei, Su, Hou-Qiang, Zhang, Qian-Nan, Wang, Li-Rong, Hao, Zhi-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999884/ https://www.ncbi.nlm.nih.gov/pubmed/27562139 http://dx.doi.org/10.1038/srep32155 |
Ejemplares similares
-
NF-κB inhibition alleviates carbon tetrachloride-induced liver fibrosis via suppression of activated hepatic stellate cells
por: WANG, FEI, et al.
Publicado: (2014) -
Lycopene improves autophagy and attenuates carbon tetrachloride-induced hepatic fibrosis in rats
por: Li, Wei, et al.
Publicado: (2023) -
Protective effects of Liuweiwuling tablets on carbon tetrachloride-induced hepatic fibrosis in rats
por: Liu, Huimin, et al.
Publicado: (2018) -
Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice
por: Wu, Ying, et al.
Publicado: (2019) -
Hepatoprotective effect of Matrine salvianolic acid B salt on Carbon Tetrachloride-Induced Hepatic Fibrosis
por: Gao, Hong-Ying, et al.
Publicado: (2012)